229 related articles for article (PubMed ID: 27622015)
1. Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.
Vila-Leahey A; Oldford SA; Marignani PA; Wang J; Haidl ID; Marshall JS
Oncoimmunology; 2016 Jul; 5(7):e1151591. PubMed ID: 27622015
[TBL] [Abstract][Full Text] [Related]
2. The impact of ranitidine on monocyte responses in the context of solid tumors.
Vila-Leahey A; Rogers D; Marshall JS
Oncotarget; 2016 Mar; 7(10):10891-904. PubMed ID: 26863636
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.
Rogers D; Vila-Leahey A; Pessôa AC; Oldford S; Marignani PA; Marshall JS
Front Immunol; 2018; 9():1894. PubMed ID: 30158936
[TBL] [Abstract][Full Text] [Related]
4. Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells.
Fukushima Y; Ishikawa T; Saitoh T; Tateishi K; Ogihara T; Fujishiro M; Shojima N; Honda M; Kushiyama A; Anai M; Sakoda H; Ono H; Onishi Y; Otsuka H; Katagiri H; Nagai R; Omata M; Asano T
Digestion; 2003; 68(2-3):145-52. PubMed ID: 14671421
[TBL] [Abstract][Full Text] [Related]
5. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
Hahm KB; Kim WH; Lee SI; Kang JK; Park IS
Scand J Gastroenterol; 1995 Mar; 30(3):265-71. PubMed ID: 7770717
[TBL] [Abstract][Full Text] [Related]
7. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells.
Hahm KB; Park IS; Kim HC; Lee KJ; Kim JH; Cho SW; Lee SI
Int J Immunopharmacol; 1996; 18(6-7):393-9. PubMed ID: 9024941
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells.
Zheng Y; Xu M; Li X; Jia J; Fan K; Lai G
Mol Immunol; 2013 May; 54(1):74-83. PubMed ID: 23220070
[TBL] [Abstract][Full Text] [Related]
10. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
11. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
12. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
14. Reversal of histamine-mediated immunosuppression by structurally diverse histamine type II (H2) receptor antagonists.
Badger AM; Young J; Poste G
Int J Immunopharmacol; 1984; 6(5):467-73. PubMed ID: 6150013
[TBL] [Abstract][Full Text] [Related]
15. Effects of the selective H1 and H2 histamine receptor antagonists loratadine and ranitidine on autonomic control of the heart.
Nault MA; Milne B; Parlow JL
Anesthesiology; 2002 Feb; 96(2):336-41. PubMed ID: 11818765
[TBL] [Abstract][Full Text] [Related]
16. Histamine-induced production of interleukin-1 alpha from murine bone marrow stromal cells and its inhibition by H2 blockers.
Tasaka K; Mio M; Shimazawa M; Nakaya N
Mol Pharmacol; 1993 Mar; 43(3):365-71. PubMed ID: 8095692
[TBL] [Abstract][Full Text] [Related]
17. Role of histamine in natural killer cell-mediated resistance against tumor cells.
Hellstrand K; Asea A; Hermodsson S
J Immunol; 1990 Dec; 145(12):4365-70. PubMed ID: 2147942
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
Krielaart MJ; Veenstra DM; van Buuren KJ
Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting binding of IT-066 to human histamine H2 receptor.
Otsuka H; Fukushima Y; Tamai M; Takahashi H; Mori H; Asano T; Katsube T; Ogawa K; Kajiwara T; Ohkawa SI; Saitoh T
Dig Dis Sci; 2000 Apr; 45(4):796-801. PubMed ID: 10759252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
